Biodosimetry based on γ-H2AX quantification and cytogenetics after partial-and total-body irradiation during fractionated radiotherapy

Radiation Research

Volumn 183, Issue 4, 2015, Pages 432-446

  Zahnreich, Sebastian ^a   Ebersberger, Anne ^a   Kaina, Bernd ^a   Schmidberger, Heinz ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOCETAXEL; DOUBLE STRANDED DNA; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; HISTONE H2AX; MERCAPTOPURINE; METHOTREXATE; MIDASTAURINE; MITOXANTRONE; PACLITAXEL; PREDNISONE; TENIPOSIDE; TIOGUANINE; UNCLASSIFIED DRUG; VINCRISTINE; H2AFX PROTEIN, HUMAN; HISTONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHROMOSOME ABERRATION; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DNA DAMAGE; DNA STRAND BREAKAGE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INTENSITY MODULATED RADIATION THERAPY; LEUKOCYTE; LINEAR ACCELERATOR; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; PARTIAL BODY RADIATION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; RADIOTHERAPY EQUIPMENT; RADIOTHERAPY PLANNING SYSTEM; WHOLE BODY RADIATION; ADVERSE EFFECTS; CALIBRATION; CHROMOSOME ANALYSIS; GENETICS; METABOLISM; MIDDLE AGED; NEOPLASMS; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RADIOMETRY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CALIBRATION; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; DNA DAMAGE; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HISTONES; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 84928527289     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR13911.1     Document Type: Article

References (45)

1. Jackson WL Jr., Gallagher C, Myhand RC, Waselenko JK. Medical management of patients with multiple organ dysfunction arising from acute radiation syndrome. BJR 2005; Suppl 27:161-8.
2. Aziz NM. Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol 2007; 46:417-32.
3. Benderitter M, Gourmelon P, Bey E, Chapel A, Clairand I, Prat M, et al. New emerging concepts in the medical management of local radiation injury. Health Phys 2010; 98:851-7.
4. Leonard A, Rueff J, Gerber GB, Leonard ED. Usefulness and limits of biological dosimetry based on cytogenetic methods. Radiat Prot Dosimetry 2005; 115:448-54.
5. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68.
6. Sak A, Grehl S, Erichsen P, Engelhard M, Grannass A, Levegrun S, et al. Gamma-H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: dependence on the dose-distribution, irradiated site and time from start of treatment. Int J Radiat Biol 2007; 83:639-52.
7. Lobrich M, Shibata A, Beucher A, Fisher A, Ensminger M, Goodarzi AA, et al. GammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle 2010; 9:662-9.
8. Lobrich M, Rief N, Kuhne M, Heckmann M, Fleckenstein J, Rube C, et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc Natl Acad Sci USA 2005; 102:8984-9.
9. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 2002; 158:486-92.
10. Cucinotta FA, Pluth JM, Anderson JA, Harper JV, O'Neill P. Biochemical kinetics model of DSB repair and induction of gamma-H2AX foci by non-homologous end joining. Radiat Res 2008; 169:214-22.
11. Redon CE, Weyemi U, Parekh PR, Huang D, Burrell AS, Bonner WM. Gamma-H2AX and other histone post-translational modifications in the clinic. Biochim Biophys Acta 2012; 1819:743-56.
12. Moroni M, Maeda D, Whitnall MH, Bonner WM, Redon CE. Evaluation of the gamma-H2AX assay for radiation biodosimetry in a swine model. Int J Mol Sci 2013; 14:14119-35.
13. Lamkowski A, Forcheron F, Agay D, Ahmed EA, Drouet M, Meineke V, et al. DNA damage focus analysis in blood samples of minipigs reveals acute partial body irradiation. PLoS One 2014; 9:e87458.
14. Redon CE, Nakamura AJ, Gouliaeva K, Rahman A, Blakely WF, Bonner WM. The use of gamma-H2AX as a biodosimeter for totalbody radiation exposure in non-human primates. PLoS One 2010; 5:e15544.
15. Zwicker F, Swartman B, Sterzing F, Major G, Weber KJ, Huber PE, et al. Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal-vs. step-and-shoot IMRT of the prostate gland. Radiat Oncol 2011; 6:62.
16. Werbrouck J, Ost P, Fonteyne V, De Meerleer G, De Neve W, Bogaert E, et al. Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT. Radiother Oncol 2013; 107:377-81.
17. Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005; 104:1129-37.
18. Gupta ML, Srivastava NN, Dutta S, Shukla SK, Dutta A, Verma S, et al. Blood biomarkers in metal scrap workers accidentally exposed to ionizing radiation: a case study. Hum Exp Toxicol 2013; 32:1311-22.
19. Rothkamm K, Barnard S, Ainsbury EA, Al-Hafidh J, Barquinero JF, Lindholm C, et al. Manual versus automated gamma-H2AX foci analysis across five European laboratories: Can this assay be used for rapid biodosimetry in a large scale radiation accident? Mutat Res 2013; 756:170-3.
20. Rothkamm K, Horn S, Scherthan H, Rossler U, De Amicis A, Barnard S, et al. Laboratory Intercomparison on the gamma-H2AX Foci Assay. Radiat Res 2013; 180:149-55.
21. Ainsbury EA, Al-Hafidh J, Bajinskis A, Barnard S, Barquinero JF, Beinke C, et al. Inter-and intra-laboratory comparison of a multibiodosimetric approach to triage in a simulated, large scale radiation emergency. Int J Radiat Biol 2014; 90:193-202.
22. Gokbuget N, Hoelzer D, Arnold R, Bohme A, Bartram CR, Freund M, et al. Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am 2000; 14:1307-25, ix.
23. Lefrere F, Delmer A, Suzan F, Levy V, Belanger C, Djabarri M, et al. Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study. Leukemia 2002; 16:587-93.
24. Horn S, Barnard S, Rothkamm K. Gamma-H2AX-based dose estimation for whole and partial body radiation exposure. PLoS One 2011; 6:e25113.
25. Cytogenetic analysis for radiation dose assessment: a manual. IAEA Technical Reports Series No. 405. Vienna, Austria: International Atomic Energy Agency; 2001.
26. Savage JR. Classification and relationships of induced chromosomal structural changes. J Med Genet 1976; 13:103-22.
27. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22:1164-71.
28. Siri WE. The gross composition of the body. Adv Biol Med Phys 1956; 4:239-80.
29. Redon CE, Nakamura AJ, Gouliaeva K, Rahman A, Blakely WF, Bonner WM. Q(gamma-H2AX), an analysis method for partialbody radiation exposure using gamma-H2AX in nonhuman primate lymphocytes. Radiat Meas 2011; 46:877-81.
30. Sasaki MS, Miyata H. Biological dosimetry in atomic bomb survivors. Nature 1968; 220:1189-93.
31. Papworth DG. Curve fitting by maximum likelihood. Radiat Bot 1975; 15:127-40.
32. Wilkins RC, Romm H, Kao TC, Awa AA, Yoshida MA, Livingston GK, et al. Interlaboratory comparison of the dicentric chromosome assay for radiation biodosimetry in mass casualty events. Radiat Res 2008; 169:551-60.
33. Sak A, Grehl S, Engelhard M, Wierlemann A, Kaelberlah HP, Erichsen P, et al. Long-term in vivo effects of cisplatin on gamma-H2AX foci signaling in peripheral lymphocytes of tumor patients after irradiation. Clin Cancer Res 2009; 15:2927-34.
34. Jacoby MA, De Jesus Pizarro RE, Shao J, Koboldt DC, Fulton RS, Zhou G, et al. The DNA double-strand break response is abnormal in myeloblasts from patients with therapy-related acute myeloid leukemia. Leukemia 2014; 28:1242-51.
35. Williams LR. Reference values for total blood volume and cardiac output in humans. Report ORNL/TM-12814. Oak Ridge, TN: Oak Ridge National Laboratory; 1994.
36. Hartel C, Nikoghosyan A, Durante M, Sommer S, Nasonova E, Fournier C, et al. Chromosomal aberrations in peripheral blood lymphocytes of prostate cancer patients treated with IMRT and carbon ions. Radiother Oncol 2010; 95:73-8.
37. d'Alesio V, Pacelli R, Durante M, Canale Cama G, Cella L, Gialanella G, et al. Lymph nodes in the irradiated field influence the yield of radiation-induced chromosomal aberrations in lymphocytes from breast cancer patients. Int J Radiat Oncol Biol Phys 2003; 57:732-8.
38. Roch-Lefevre S, Pouzoulet F, Giraudet AL, Voisin P, Vaurijoux A, Gruel G, et al. Cytogenetic assessment of heterogeneous radiation doses in cancer patients treated with fractionated radiotherapy. Br J Radiol 2010; 83:759-66.
39. Edwards AA. The use of chromosomal aberrations in human lymphocytes for biological dosimetry. Radiat Res 1997; 148:S39-44.
40. Durante M, Yamada S, Ando K, Furusawa Y, Kawata T, Majima H, et al. Measurements of the equivalent whole-body dose during radiation therapy by cytogenetic methods. Phys Med Biol 1999; 44:1289-98.
41. Ekstrand KE, Dixon RL, Plunkett S, Raben M. The calculation of the dose to lymphocytes in external beam radiation therapy. Radiat Res 1981; 85:399-407.
42. Chee CA, Ilbery PL, Rickinson AB. Depression of lymphocyte replicating ability in radiotherapy patients. Br J Radiol 1974; 47:37-43.
43. Jones TD, Morris MD, Young RW. A mathematical model for radiation-induced myelopoiesis. Radiat Res 1991; 128:258-66.
44. Mariotti LG, Pirovano G, Savage KI, Ghita M, Ottolenghi A, Prise KM, et al. Use of the gamma-H2AX assay to investigate dna repair dynamics following multiple radiation exposures. PLoS One 2013; 8:e79541.
45. Dossou J, Lartigau E, M'Kacher R, Legal JD, Bridier A, Guichard M, et al. Biological dosimetry after total body irradiation (TBI) for hematologic malignancy patients. Int J Radiat Oncol Biol Phys 2000; 46:123-9.